EX-8

EX-8 2 d189973dex8.htm EX-8 EX-8

Exhibit 8

Dr. Reddy’s Laboratories Limited

Dr. Reddy’s Laboratories Limited is the parent company. Tabulated below is the list of subsidiaries, associates and joint ventures as of March 31, 2016:


Name of the subsidiary	Country of Incorporation	Percentage of Direct/Indirect Ownership Interest
Aurigene Discovery Technologies (Malaysia) Sdn. Bhd.	Malaysia		100	%⁽³⁾
Aurigene Discovery Technologies Inc.	U.S.A.		100	%⁽³⁾
Aurigene Discovery Technologies Limited	India		100	%
beta Institut gemeinnützige GmbH	Germany		100	%⁽⁸⁾
betapharm Arzneimittel GmbH	Germany		100	%⁽⁸⁾
Cheminor Investments Limited	India		100	%
Chienna B.V.	Netherlands		100	%⁽¹³⁾
Chirotech Technology Limited	United Kingdom		100	%⁽⁵⁾
DRANU LLC	U.S.A.		50	%⁽¹⁵⁾
Dr. Reddy’s Bio-Sciences Limited	India		100	%
Dr. Reddy’s Farmaceutica Do Brasil Ltda.	Brazil		100	%
Dr. Reddy’s Laboratories (Australia) Pty. Limited	Australia		100	%⁽¹⁰⁾
Dr. Reddy’s Laboratories Canada, Inc.	Canada		100	%⁽¹⁰⁾
Dr. Reddy’s Laboratories (EU) Limited	United Kingdom		100	%⁽¹⁰⁾
Dr. Reddy’s Laboratories Inc.	U.S.A.		100	%⁽¹⁰⁾
Dr. Reddy’s Laboratories International SA	Switzerland		100	%⁽¹⁰⁾
Dr. Reddy’s Laboratories Japan KK (from April 21, 2015)	Japan		100	%⁽¹⁰⁾
Dr. Reddy’s Laboratories, LLC	Ukraine		100	%⁽¹⁰⁾
Dr. Reddy’s Laboratories Louisiana LLC	U.S.A.		100	%⁽⁶⁾
Dr. Reddy’s Laboratories New York, Inc.	U.S.A.		100	%⁽¹⁰⁾
Dr. Reddy’s Laboratories (Proprietary) Limited	South Africa		100	%⁽¹⁰⁾
Dr. Reddy’s Laboratories Romania S.R.L.	Romania		100	%⁽¹⁰⁾
Dr. Reddy’s Laboratories SA	Switzerland		100	%
Dr. Reddy’s Laboratories SAS (from November 4, 2014)	Colombia		100	%⁽¹⁰⁾
Dr. Reddy’s Laboratories Tennessee, LLC	U.S.A.		100	%⁽⁶⁾
Dr. Reddy’s Laboratories (UK) Limited	United Kingdom		100	%⁽⁵⁾
Dr. Reddy’s New Zealand Limited.	New Zealand		100	%⁽¹⁰⁾
Dr. Reddy’s Pharma SEZ Limited	India		100	%
Dr. Reddy’s Singapore PTE Limited	Singapore		100	%⁽¹⁰⁾
Dr. Reddy’s Srl	Italy		100	%⁽¹¹⁾
Dr. Reddy’s Venezuela, C.A.	Venezuela		100	%⁽¹⁰⁾
DRL Impex Limited	India		100	%
Eurobridge Consulting B.V.	Netherlands		100	%⁽¹⁾
Industrias Quimicas Falcon de Mexico, S.A. de CV	Mexico		100	%
Idea2Enterprises (India) Pvt. Limited	India		100	%
Kunshan Rotam Reddy Pharmaceutical Co. Limited	China		51.33	%⁽⁴⁾
Lacock Holdings Limited	Cyprus		100	%⁽¹⁰⁾
OOO Dr. Reddy’s Laboratories Limited	Russia		100	%⁽¹⁰⁾
OOO DRS LLC	Russia		100	%⁽⁹⁾
OctoPlus B.V. (formerly OctoPlus N.V.)	Netherlands		100	%⁽¹²⁾
OctoPlus Development B.V.	Netherlands		100	%⁽¹³⁾
OctoPlus Sciences B.V.	Netherlands		100	%⁽¹³⁾
OctoPlus PolyActive Sciences B.V.	Netherlands		100	%⁽¹⁴⁾
OctoPlus Technologies B.V.	Netherlands		100	%⁽¹³⁾
OctoShare B.V.	Netherlands		100	%⁽¹³⁾
Promius Pharma LLC	U.S.A.		100	%⁽⁶⁾
Reddy Antilles N.V.	Netherlands		100	%
Reddy Specialities GmbH (till November 21, 2015)	Germany		100	%⁽⁸⁾
Reddy Cheminor S.A.	France		100	%⁽²⁾
Reddy Holding GmbH	Germany		100	%⁽¹⁰⁾
Reddy Netherlands B.V.	Netherlands		100	%⁽¹⁰⁾


Name of the subsidiary	Country of Incorporation	Percentage of Direct/Indirect Ownership Interest
Reddy Pharma Iberia SA	Spain		100	%
Reddy Pharma Italia S.R.L. (formerly Reddy Pharma Italia S.p.A.)	Italy		100	%⁽⁷⁾
Reddy Pharma SAS (from October 29, 2015)	France		100	%⁽¹⁰⁾
DRSS Solar Power Private Limited	India		26	%⁽¹⁶⁾
DRES Solar Power Private Limited (from October 6, 2015)	India		26	%⁽¹⁶⁾

(1)	Indirectly owned through Reddy Antilles N.V.

(2)	Subsidiary under liquidation.

(3)	Indirectly owned through Aurigene Discovery Technologies Limited.

(4)	Kunshan Rotam Reddy Pharmaceutical Co. Limited is a subsidiary, as we hold a 51.33% stake. However, we account for this investment by the equity method and do not consolidate it in our financial statements.

(5)	Indirectly owned through Dr. Reddy’s Laboratories (EU) Limited.

(6)	Indirectly owned through Dr. Reddy’s Laboratories Inc.

(7)	Indirectly owned through Lacock Holdings Limited.

(8)	Indirectly owned through Reddy Holding GmbH.

(9)	Indirectly owned through Eurobridge Consulting B.V.

(10)	Indirectly owned through Dr. Reddy’s Laboratories SA.

(11)	Indirectly owned through Reddy Pharma Italia S.R.L.

(12)	Indirectly owned through Reddy Netherlands B.V.

(13)	Indirectly owned through OctoPlus B.V.

(14)	Indirectly owned through OctoPlus Sciences B.V.

(15)	DRANU LLC is consolidated in accordance with guidance available in IFRS 10.

(16)	Accounted in accordance with IFRS 11 ‘Joint Arrangements’.